Author
@investseekers investseekers
grade Bx.com/investseekers ↗
Obsessive GLP-1/obesity-drug analyst tracking the Novo-vs-Lilly battleground in granular depth
Aggregates and analyzes the GLP-1 / obesity-drug space, synt
trader score
-0.65
hit rate
30%
mean α
-0.22%
signals 14d
124
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 30% hit rate, -0.22% mean alpha, trader score -0.65. Their last-14d mentions, direction-adjusted, have moved -0.7% since posting (mean over 109 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-08-28 | LLY | @investseekers | +0.20 | Reports legal and enforcement actions against counterfeit weight-loss drugs. | — | tweet ↗ |
| 2026-08-28 | NVO | @investseekers | +0.20 | Reports legal and enforcement actions against counterfeit weight-loss drugs. | — | tweet ↗ |
| 2026-08-28 | LLY | @investseekers | +0.35 | Compares explicit weekly prescription volumes and obesity-market shares. | — | tweet ↗ |
| 2026-08-28 | NVO | @investseekers | +0.35 | Compares explicit weekly prescription volumes and obesity-market shares. | — | tweet ↗ |
| 2026-08-28 | LLY | @investseekers | +0.00 | Points to an updated visual tracking both oral obesity-drug launches. | — | tweet ↗ |
| 2026-08-28 | NVO | @investseekers | +0.00 | Points to an updated visual tracking both oral obesity-drug launches. | — | tweet ↗ |
| 2026-08-28 | LLY | @investseekers | +0.25 | Reports and compares new weekly prescription data for both drugs. | — | tweet ↗ |
| 2026-08-28 | NVO | @investseekers | +0.35 | Reports and compares new weekly prescription data for both drugs. | — | tweet ↗ |
| 2026-08-28 | LLY | @investseekers | +0.50 | FDA expanded Mounjaro's label to reduce major cardiovascular-event risk. | — | tweet ↗ |
| 2026-08-28 | NVO | @investseekers | +0.25 | Reports Oral Wegovy launching in Germany on Tuesday. | — | tweet ↗ |
| 2026-08-28 | LLY | @investseekers | +0.25 | GLP-1 adoption is framed as creating second-order opportunities across industries. | — | tweet ↗ |
| 2026-08-28 | NVO | @investseekers | +0.25 | GLP-1 adoption is framed as creating second-order opportunities across industries. | — | tweet ↗ |
| 2026-08-27 | LLY | @investseekers | -0.25 | Prescription data show Oral Wegovy far ahead despite faster Foundayo percentage growth. | -0.1% | tweet ↗ |
| 2026-08-27 | NVO | @investseekers | +0.45 | Prescription data show Oral Wegovy far ahead despite faster Foundayo percentage growth. | -1.4% | tweet ↗ |
| 2026-08-27 | NVO | @investseekers | +0.15 | ADR pricing implies a slightly positive Copenhagen open. | -1.4% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.